1. bookVolume 54 (2020): Issue 1 (January 2020)
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Open Access

Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells

Published Online: 01 Feb 2020
Volume & Issue: Volume 54 (2020) - Issue 1 (January 2020)
Page range: 31 - 42
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Abstract

Objective. The aim of the present study was to investigate the effect of adipokine NAMPT (nicotinamide phosphoribosyltransferase) silencing on the expression of genes encoding IRS1 (insulin receptor substrate 1) and some other proliferation related proteins in U87 glioma cells for evaluation of the possible significance of this adipokine in intergenic interactions.

Methods. The silencing of NAMPT mRNA was introduced by NAMPT specific siRNA. The expression level of NAMPT, IGFBP3, IRS1, HK2, PER2, CLU, BNIP3, TPD52, GADD45A, and MKI67 genes was studied in U87 glioma cells by quantitative polymerase chain reaction. Anti-visfatin antibody was used for detection of NAMPT protein by Western-blot analysis.

Results. It was shown that the silencing of NAMPT mRNA led to a strong down-regulation of NAMPT protein and significant modification of the expression of IRS1, IGFBP3, CLU, HK2, BNIP3, and MKI67 genes in glioma cells and a strong up-regulation of IGFBP3 and IRS1 and down-regulation of CLU, BNIP3, HK2, and MKI67 gene expressions. At the same time, no significant changes were detected in the expression of GADD45A, PER2, and TPD52 genes in glioma cells treated by siRNA specific to NAMPT. Furthermore, the silencing of NAMPT mRNA suppressed the glioma cell proliferation.

Conclusions. Results of this investigation demonstrated that silencing of NAMPT mRNA with corresponding down-regulation of NAMPT protein and suppression of the glioma cell proliferation affected the expression of IRS1 gene as well as many other genes encoding the proliferation related proteins. It is possible that dysregulation of most of the studied genes in glioma cells after silencing of NAMPT is reflected by a complex of intergenic interactions and that NAMPT is an important factor for genome stability and regulatory mechanisms contributing to the control of glioma cell metabolism and proliferation.

Keywords

Abu Aboud O, Chen CH, Senapedis W, Baloglu E, Argueta C, Weiss RH. Dual and specific inhibition of NAMPT and PAK4 by KPT-9274 decreases kidney cancer growth. Mol Cancer Ther 15, 2119–2129, 2016.10.1158/1535-7163.MCT-16-0197501093227390344Search in Google Scholar

Alaee M, Khaghani S, Behroozfar K, Hesari Z, Ghorbanhosseini SS, Nourbakhsh M. Inhibition of ncotinamide phosphoribosyltransferase induces apoptosis in estrogen receptor-positive MCF-7 breast cancer cells. J Breast Cancer 20, 20–26, 2017.10.4048/jbc.2017.20.1.20537857628382091Open DOISearch in Google Scholar

Annie L, Gurusubramanian G, Roy VK. Estrogen and progesterone dependent expression of visfatin/NAMPT regulates proliferation and apoptosis in mice uterus during estrous cycle. J Steroid Biochem Mol Biol 185, 225–236, 2019.10.1016/j.jsbmb.2018.09.01030227242Search in Google Scholar

Armstead VE, Minchenko AG, Campbell B, Lefer AM. P-selectin is up-regulated in vital organs during murine traumatic shock. FASEB J 11, 1271–1279, 1997.10.1096/fasebj.11.14.94095469409546Open DOISearch in Google Scholar

Bong IP, Ng CC, Fakiruddin SK, Lim MN, Zakaria Z. Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study. Bosn J Basic Med Sci 16, 268–275, 2016.Search in Google Scholar

Canel M, Byron A, Sims AH, Cartier J, Patel H, Frame MC, Brunton VG, Serrels B, Serrels A. Nuclear FAK and Runx1 cooperate to regulate IGFBP3, cell-cycle progression, and tumor growth. Cancer Res 77, 5301–5312, 2017.10.1158/0008-5472.CAN-17-0418612661528807942Search in Google Scholar

Carbone F, Liberale L, Bonaventura A, Vecchie A, Casula M, Cea M, Monacelli F, Caffa I, Bruzzone S, Montecucco F, Nencioni A. Regulation and function of extracellular nicotinamide phosphoribosyltransferase/visfatin. Compr Physiol 7, 603–662, 2017.2833338210.1002/cphy.c16002928333382Search in Google Scholar

Cheleschi S, Giordano N, Volpi N, Tenti S, Gallo I, Di Meglio M, Giannotti S, Fioravanti A. A Complex Relationship between Visfatin and Resistin and microRNA: An in vitro study on human chondrocyte cultures. Int J Mol Sci 19, E3909, 2018.10.3390/ijms19123909632083230563239Open DOISearch in Google Scholar

Chen J, Zhang S, Li Y, Tang Z, Kong W. Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma. Tumour Biol 35, 3743–3753, 2014.10.1007/s13277-013-1496-22436306124363061Open DOISearch in Google Scholar

Chen J, Yu Y, Li H, Hu Q, Chen X, He Y, Xue C, Ren F, Ren Z, Li J, Liu L, Duan Z, Cui G, Sun R. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer 18, 33, 2019.10.1186/s12943-019-0947-9639774630825877Search in Google Scholar

Fan X, Wang Y, Jiang T, Cai W, Jin Y, Niu Y, Zhu H, Bu Y. B-Myb mediates proliferation and migration of non-small-cell lung cancer via suppressing IGFBP3. Int J Mol Sci 19, E1479, 2018.10.3390/ijms19051479598369329772705Open DOISearch in Google Scholar

Feng J, Yan PF, Zhao HY, Zhang FC, Zhao WH, Feng M. Inhibitor of nicotinamide phosphoribosyltransferase sensitizes glioblastoma cells to temozolomide via activating ROS/JNK signaling pathway. Biomed Res Int 2016, 1450843, 2016.10.1155/2016/1450843520641128097126Search in Google Scholar

Flehmig G, Scholz M, Kloting N, Fasshauer M, Tonjes A, Stumvoll M, Youn BS, Bluher M. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS One 9, e99785, 2014.2496809810.1371/journal.pone.0099785407267224968098Search in Google Scholar

Goktas Z, Owens S, Boylan M, Syn D, Shen CL, Reed DB, San Francisco S, Wang S. Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects. Mediators Inflamm 2013, 861496, 2013.10.1155/2013/861496386678824367155Search in Google Scholar

Hesari Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, Alipour M, Tavakoli-Yaraki M, Ghorbanhosseini SS, Yousefi Z, Jafarzadeh M, Yarahmadi S. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells. Gene 673, 149–158, 2018.10.1016/j.gene.2018.06.02129886033Search in Google Scholar

Hu Y, Jin R, Gao M, Xu H, Zou S, Li X, Xing C, Wang Q, Wang H, Feng J, Hu M, Song L. Transcriptional repression of IKKbeta by p53 in arsenite-induced GADD45alpha accumulation and apoptosis. Oncogene 38, 731–746, 2019.10.1038/s41388-018-0478-7635565030177839Search in Google Scholar

Huang Z, Tian G, Cheng S, Zhao D, Zhang Y, Jia Y, Zhou F. Polydatin attenuates atherosclerosis in ApoE-/- mice through PBEF mediated reduction of cholesterol deposition. Am J Chin Med 46, 1841–1859, 2018.10.1142/S0192415X1850092130537866Search in Google Scholar

Ingermann AR, Yang YF, Han J, Mikami A, Garza AE, Mohanraj L, Fan L, Idowu M, Ware JL, Kim HS, Lee DY, Oh Y. Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem 285, 30233–30246, 2010.10.1074/jbc.M110.122226294327820353938Search in Google Scholar

Li H, Bai E, Zhang Y, Jia Z, He S, Fu J. Role of nampt and visceral adiposity in esophagogastric junction adenocarcinoma. J Immunol Res 2017, 3970605, 2017.2816820510.1155/2017/3970605526680828168205Search in Google Scholar

Li H, Yu L, Zhao C. Dioscin attenuates high-fat diet-induced insulin resistance of adipose tissue through the IRS-1/PI3K/Akt signaling pathway. Mol Med Rep 19, 1230–1237, 2019.10.3892/mmr.2018.970030483735Search in Google Scholar

Liang N, Chen Y, Yang L, He S, Liu T. Visfatin increases miR-21 to promote migration in HCC. Cell Mol Biol (Noisy-le-grand) 64, 48–52, 2018.10.14715/cmb/2018.64.6.9Open DOISearch in Google Scholar

Liu Y, Men C, Xu Y, Zhao K, Luo L, Dong D, Yu Q. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression. Cancer Biomark 21, 915–923, 2018.10.3233/CBM-1710182940066329400663Open DOISearch in Google Scholar

Lucena-Cacace A, Otero-Albiol D, Jimenez-Garcia MP, Peinado-Serrano J, Carnero A. NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis. Oncotarget 8, 99514–99530, 2017.10.18632/oncotarget.20577572511129245920Search in Google Scholar

Meram AT, Alzubaidi Y, Cotelingam J, Ghali G, Lopez L, Coppola D, Shackelford R. Nicotinamide phosphoribosyl transferase is increased in osteosarcomas and chondrosarcomas compared to benign bone and cartilage. Anticancer Res 39, 1761–1765, 2019.10.21873/anticanres.13282777130830952715Search in Google Scholar

Minchenko OH, Opentanova IL, Minchenko DO, Ogura T, Esumi H. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 gene via hypoxia-inducible factor-1alpha activation. FEBS Lett 576, 14–20, 2004.10.1016/j.febslet.2004.08.05315474002Search in Google Scholar

Minchenko DO, Novik YE, Maslak HS, Tiazhka OV, Minchenko OH. Expression of PFKFB, HK2, NAMPT, TSPAN13 and HSPB8 genes in pediatric glioma. Lik Sprava 7–8, 43–48, 2015a.Search in Google Scholar

Minchenko OH, Tsymbal DO, Minchenko DO, Moenner M, Kovalevska OV, Lypova NM. Inhibition of kinase and endoribonuclease activity of ERN1/IRE1 affects expression of proliferation-related genes in U87 glioma cells. Endoplasm Reticul Stress Dis 2, 18–29, 2015b.10.1515/ersc-2015-0002Search in Google Scholar

Nedic O, Robajac D, Sunderic M, Miljus G, Dukanovic B, Malenkovic V. Detection and identification of oxidized insulin-like growth factor-binding proteins and receptors in patients with colorectal carcinoma. Free Radic Biol Med 65, 1195–1200, 2013.10.1016/j.freeradbiomed.2013.09.00324051179Search in Google Scholar

Nielsen KN, Peics J, Ma T, Karavaeva I, Dall M, Chubanava S, Basse AL, Dmytriyeva O, Treebak JT, Gerhart-Hines Z. NAMPT-mediated NAD+ biosynthesis is indispensable for adipose tissue plasticity and development of obesity. Mol Metab 11, 178–188, 2018.10.1016/j.molmet.2018.02.014600135529551635Search in Google Scholar

Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L, Wang Y, Li X, Xiong XF, Wei B, Wu X, Wan G. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18, 46, 2019.10.1186/s12943-019-1004-4643793230922314Search in Google Scholar

Ohanna M, Cerezo M, Nottet N, Bille K, Didier R, Beranger G, Mograbi B, Rocchi S, Yvan-Charvet L, Ballotti R, Bertolotto C. Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype. Genes Dev 32, 448–461, 2018.2956776610.1101/gad.305854.117590071629567766Search in Google Scholar

Olszanecka-Glinianowicz M, Owczarek A, Bozentowicz-Wikarek M, Brzozowska A, Mossakowska M, Zdrojewski T, Grodzicki T, Wiecek A, Chudek J. Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population - results from the PolSenior substudy. Metabolism 63, 1409–1418, 2014.10.1016/j.metabol.2014.07.01325172122Open DOISearch in Google Scholar

Poljsak B. NAMPT-mediated NAD biosynthesis as the internal timing mechanism: In NAD+ world, time is running in its own way. Rejuvenation Res 21, 210–224, 2018.10.1089/rej.2017.197528756747Search in Google Scholar

Qu M, Duffy T, Hirota T, Kay SA. Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks. Proc Natl Acad Sci USA 115, E12305–E12312, 2018.10.1073/pnas.1816411115631082130530698Search in Google Scholar

Rahman S, Kraljevic Pavelic S, Markova-Car E. Circadian (de)regulation in head and neck squamous cell carcinoma. Int J Mol Sci 20, E2662, 2019.10.3390/ijms20112662660014331151182Open DOISearch in Google Scholar

Shackelford RE, Mayhall K, Maxwell NM, Kandil E, Coppola D. Nicotinamide phosphoribosyltransferase in malignancy: a review. Genes Cancer 4, 447–56, 2013.10.1177/1947601913507576387766524386506Search in Google Scholar

Shao Y, Liu Z, Liu J, Wang H, Huang L, Lin T, Liu J, Wei Q, Zeng H, He G, Li X. Expression and epigenetic regulatory mechanism of BNIP3 in clear cell renal cell carcinoma. Int J Oncol 54, 348–360, 2019.3036513710.3892/ijo.2018.4603625493230365137Search in Google Scholar

Singh A, Azad M, Shymko MD, Henson ES, Katyal S, Eisenstat DD, Gibson SB. The BH3 only Bcl-2 family member BNIP3 regulates cellular proliferation. PLoS ONE 13, e0204792, 2018.10.1371/journal.pone.0204792618130030307949Search in Google Scholar

Shi C, Wu H, Du D, Im HJ, Zhang Y, Hu B, Chen H, Wang X, Liu Y, Cao P, Tian Y, Shen X, Gao R, van Wijnen AJ, Ye X, Yuan W. Nicotinamide phosphoribosyltransferase inhibitor APO866 prevents IL-1beta-induced human nucleus pulposus cell degeneration via autophagy. Cell Physiol Biochem 49, 2463–2482, 2018.10.1159/00049384330261504Search in Google Scholar

Sun Y, Zhou J, Shi L, Li J, Chen J. MicroRNA-466 inhibits cell proliferation and invasion in osteosarcoma by directly targeting insulin receptor substrate 1. Mol Med Rep 19, 3345–3352, 2019.10.3892/mmr.2019.995630816452Search in Google Scholar

Tabassum A, Zaidi SNF, Yasmeen K, Mahboob T. Potential role of peroxisome proliferator activated receptor gamma activation on serum visfatin and trace elements in high fat diet induced type 2 diabetes mellitus. Life Sci 205, 164–175, 2018.10.1016/j.lfs.2018.05.02729772226Search in Google Scholar

Tu W, Yang B, Leng X, Pei X, Xu J, Liu M, Dong Q, Tao D, Lu Y, Liu Y, Yang Y. Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression. Cancer Sci 110, 1573–1586, 2019.10.1111/cas.13984650103630815935Search in Google Scholar

Wang HH, Wang YC, Wu DW, Hung CS, Chen CY, Lee H. Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer. Tumour Biol 39, 1010428317694316, 2017.10.1177/101042831769431628378642Search in Google Scholar

Wang Y, Chen CL, Pan QZ, Wu YY, Zhao JJ, Jiang SS, Chao J, Zhang XF, Zhang HX, Zhou ZQ, Tang Y, Huang XQ, Zhang JH, Xia JC. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget 7, 6323–6334, 2016.2657517010.18632/oncotarget.6319486875926575170Search in Google Scholar

Wu L, Li Y, Li J, Ma D. MicroRNA-664 targets insulin receptor substrate 1 to suppress cell proliferation and invasion in breast cancer. Oncol Res 27, 459–467, 2019.10.3727/096504018X15193500663936784846729495974Search in Google Scholar

Xiang R, Cui Y, Wang Y, Xie T, Yang X, Wang Z, Li J, Li Q. Circadian clock gene Per2 downregulation in nonsmall cell lung cancer is associated with tumour progression and metastasis. Oncol Rep 40, 3040–3048, 2018.10.3892/or.2018.670430226549Search in Google Scholar

Xiong H, Yang Y, Yang K, Zhao D, Tang H, Ran X. Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer. Int J Oncol 52, 279–287, 2018.10.3892/ijo.2017.418029115399Search in Google Scholar

Xu H, Lee MS, Tsai PY, Adler AS, Curry NL, Challa S, Freinkman E, Hitchcock DS, Copps KD, White MF, Bronson RT, Marcotrigiano M, Wu Y, Clish CB, Kalaany NY. Ablation of insulin receptor substrates 1 and 2 suppresses Kras-driven lung tumorigenesis. Proc Natl Acad Sci USA 115, 4228–4233, 2018.10.1073/pnas.1718414115591083729610318Search in Google Scholar

Xu R, Yuan Z, Yang L, Li L, Li D, Lv C. Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress. Oncol Rep 38, 1767–1773, 2017.2871403410.3892/or.2017.579328714034Search in Google Scholar

Yan J, Yang X, Li L, Liu P, Wu H, Liu Z, Li Q, Liao G, Wang X. Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma. Oncol Lett 13, 3395–3402, 2017.2852144510.3892/ol.2017.5934543139828521445Search in Google Scholar

Yoo JJ, Yu SJ, Na J, Kim K, Cho YY, Lee YB, Cho EJ, Lee JH, Kim YJ, Youn H, Yoon JH. Hexokinase-II inhibition synergistically augments the anti-tumor efficacy of sorafenib in hepatocellular carcinoma. Int J Mol Sci 20, E1292, 2019.10.3390/ijms20061292647130230875800Search in Google Scholar

Zhao H, Tang W, Chen X, Wang S, Wang X, Xu H, Li L. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells. Biochem Biophys Res Commun 493, 77–84, 2017.10.1016/j.bbrc.2017.09.07128919418Search in Google Scholar

Zhang LQ, Van Haandel L, Xiong M, Huang P, Heruth DP, Bi C, Gaedigk R, Jiang X, Li DY, Wyckoff G, Grigoryev DN, Gao L, Li L, Wu M, Leeder JS, Ye SQ. Metabolic and molecular insights into an essential role of nicotin-amide phosphoribosyltransferase. Cell Death Dis 8, e2705, 2017.10.1038/cddis.2017.132538653528333140Search in Google Scholar

Zhang Y, Li Y, Wang J, Lei P. Long noncoding RNA ferritin heavy polypeptide 1 pseudogene 3 controls glioma cell proliferation and apoptosis via regulation of the microRNA2245p/tumor protein D52 axis. Mol Med Rep 18, 4239–4246, 2018.10.3892/mmr.2018.9491617240430221720Search in Google Scholar

Zhou N, Sun Z, Li N, Ge Y, Zhou J, Han Q, Zhao L, Bai C. miR197 promotes the invasion and migration of colorectal cancer by targeting insulin-like growth factor-binding protein 3. Oncol Rep 40, 2710–2721, 2018.10.3892/or.2018.664030106114Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo